Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer.

Qiong WangZean LiJin YangShirong PengQianghua ZhouKai YaoWenli CaiZhongqiu XieFujun QinHui LiXu ChenKaiwen Li Hai Huang

Published in: Cancer biology & medicine (2021)

We demonstrated that NEIL3 may serve as a diagnostic or therapeutic target for therapy-resistant patients.

Keyphrases